Biomarkers

Follow
Researchers at the University of Missouri in a lab studying agmatine and thiamine as biomarkers for early glaucoma detection, with vials and eye scans visible.
Image generated by AI

Mizzou researchers identify molecules for early glaucoma detection

Reported by AI Image generated by AI Fact checked

Scientists at the University of Missouri report that two natural molecules — agmatine and thiamine — are reduced in samples from glaucoma patients and could serve as early biomarkers. In preclinical work, the compounds also showed signs of protecting retinal cells, suggesting a path to earlier detection and potential neuroprotective therapies.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline